107 related articles for article (PubMed ID: 8100852)
1. Expression of the multidrug resistance gene in osteosarcoma: a pilot study.
Wunder JS; Bell RS; Wold L; Andrulis IL
J Orthop Res; 1993 May; 11(3):396-403. PubMed ID: 8100852
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.
Imanishi T; Abe Y; Suto R; Higaki S; Ueyama Y; Nakamura M; Tamaoki N; Fukuda H; Imai N
Tokai J Exp Clin Med; 1994 Sep; 19(1-2):39-46. PubMed ID: 7660382
[TBL] [Abstract][Full Text] [Related]
3. MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndrome.
Zöchbauer S; Gsur A; Götzl M; Wallner J; Lechner K; Pirker R
Anticancer Res; 1994; 14(3B):1293-5. PubMed ID: 7915092
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer.
Arao S; Suwa H; Mandai M; Tashiro H; Miyazaki K; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Mar; 54(5):1355-9. PubMed ID: 7509719
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
7. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.
Serra M; Scotlandi K; Manara MC; Maurici D; Lollini PL; De Giovanni C; Toffoli G; Baldini N
Anticancer Res; 1993; 13(2):323-9. PubMed ID: 8100126
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers.
Kakehi Y; Wu WJ; Kim WJ; Arao S; Fukumoto M; Yoshida O
Int J Urol; 1995 Nov; 2(5):309-15. PubMed ID: 8749949
[TBL] [Abstract][Full Text] [Related]
10. MDR-1 expression in metastatic malignant melanoma.
Levine EA; Holzmayer TA; Roninson IB; Das Gupta TK
J Surg Res; 1993 Jun; 54(6):621-4. PubMed ID: 8105147
[TBL] [Abstract][Full Text] [Related]
11. Expression of the multidrug resistance gene in human tumors.
Kim R
Hiroshima J Med Sci; 1990 Sep; 39(3):71-7. PubMed ID: 1980915
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of methotrexate resistance in osteosarcoma.
Guo W; Healey JH; Meyers PA; Ladanyi M; Huvos AG; Bertino JR; Gorlick R
Clin Cancer Res; 1999 Mar; 5(3):621-7. PubMed ID: 10100715
[TBL] [Abstract][Full Text] [Related]
13. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Ifergan I; Meller I; Issakov J; Assaraf YG
Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
[TBL] [Abstract][Full Text] [Related]
14. MDR1 (multidrug resistance) gene expression in adult acute leukemia: correlations with blast phenotype.
Miyachi H; Takemura Y; Yonekura S; Komatsuda M; Nagao T; Arimori S; Ando Y
Int J Hematol; 1993 Jan; 57(1):31-7. PubMed ID: 8477061
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours.
McDowell H; Peuchmaur M; Dominici C; Flamant F
Anticancer Res; 1993; 13(5C):1863-6. PubMed ID: 7903523
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
17. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
18. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
[TBL] [Abstract][Full Text] [Related]
20. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
